<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01964781</url>
  </required_header>
  <id_info>
    <org_study_id>2012-004964-23</org_study_id>
    <secondary_id>2012-004964-23</secondary_id>
    <nct_id>NCT01964781</nct_id>
  </id_info>
  <brief_title>The Effect of Topical Administration of Common Drugs on Postoperative Bleeding and Pain</brief_title>
  <official_title>The Effect of Topical Administration of Tranexamic Acid, Adrenaline and Bupivacain on Postoperative Bleeding and Pain in Patients Undergoing Breast Surgery. A Four-armed Placebo-controlled Double Blinded Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Olavs Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      After surgical procedures, interventions to reduce postoperative pain and bleeding are of
      great importance. In this study, the effect will be investigated of smearing common drugs,
      which are designed for injection, directly onto the raw wound surface (topical application)
      created during surgery. Topical application allows a small amount of drug to reach a large
      wound area, higher drug concentration in the exposed wound surface but very low concentration
      in the body, and no risk of injury from needles. Although beneficial effects of such an easy
      and low-cost intervention would be expected, the investigators have found no previous reports
      on blinded and controlled studies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The drugs to be studied on whether they reduce bleeding are adrenaline (constricts blood
      vessels) and tranexamic acid (TXA) (prevents bloodclots from dissolving). The drug studied to
      what extent it reduces pain will be bupivacaine, a common local anaesthetic. Patients
      undergoing bilateral symmetric breast surgery or single sided mastectomies are candidates for
      enrollment in the study. The bilateral patients will have two identical procedures and hence
      two identical wounds in the same patient. This enables the investigators to use one side as
      control and hence design our study arms as prospective and placebo-controlled. The patients
      undergoing a one-sided procedure will need to be compared to similar patients, but as wounds
      will be of different sizes and in different people, larger groups are needed to find
      significant differences between treatment and controls.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of blood on drains postoperatively</measure>
    <time_frame>24 hours postoperatively</time_frame>
    <description>Drains are placed in surgical wounds during operation, and amount of blood on drains measured in ml on the control after 24 hours.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Amount of pain in operated breast</measure>
    <time_frame>Measured 24 hours postoperatively</time_frame>
    <description>Evaluate using a visual analogue scale the pain in the surgical wounds as reported by the patient 24 hours postoperatively</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Postoperative Hemorrhage</condition>
  <arm_group>
    <arm_group_label>topical tranexamic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>tranexamic acid to be smeared on surgical wounds before closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>topical adrenaline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>adrenaline solution to be smeared on surgical wounds before closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>topical bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>bupivacaine to be smeared on surgical wounds before closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>topical adrenaline plus tranexamic acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>tranexamic acid and adrenaline to be smeared on surgical wounds before closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>saline to be smeared on surgical wounds before closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tranexamic acid and placebo control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>tranexamic acid and saline to be smeared on surgical wounds before closure</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic Acid</intervention_name>
    <description>Topical administration - does it reduce surgical bleeding?</description>
    <arm_group_label>topical tranexamic acid</arm_group_label>
    <arm_group_label>topical adrenaline plus tranexamic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>Topical Bupivacaine- does it reduce surgical pain?</description>
    <arm_group_label>topical bupivacaine</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Adrenaline</intervention_name>
    <description>Topical adrenaline - does it reduce bleeding on its own, and does it enhance the effect of tranexamic acid?</description>
    <arm_group_label>topical adrenaline</arm_group_label>
    <arm_group_label>topical adrenaline plus tranexamic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tranexamic acid plus saline</intervention_name>
    <arm_group_label>tranexamic acid and placebo control</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <arm_group_label>placebo control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing unilateral simple mastectomy

          -  patients undergoing bilateral symmetric breast surgery

        Exclusion Criteria:

          -  pregnancy

          -  A history of former thromboembolic events (to receive TXA)

          -  cardiovascular disease (to receive adrenaline)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hilde Pleym, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>St. Olavs Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St Olavs University Hospital</name>
      <address>
        <city>Trondheim</city>
        <zip>7006</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <results_reference>
    <citation>Ausen K, Fossmark R, Spigset O, Pleym H. Randomized clinical trial of topical tranexamic acid after reduction mammoplasty. Br J Surg. 2015 Oct;102(11):1348-53. doi: 10.1002/bjs.9878.</citation>
    <PMID>26349843</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2013</study_first_submitted>
  <study_first_submitted_qc>October 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2013</study_first_posted>
  <last_update_submitted>March 6, 2017</last_update_submitted>
  <last_update_submitted_qc>March 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Administration, topical</keyword>
  <keyword>tranexamic acid</keyword>
  <keyword>adrenaline</keyword>
  <keyword>bupivacaine</keyword>
  <keyword>surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Postoperative Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

